Celecoxib + Pregabalin for Managing Postoperative Analgesia in Patients Undergoing TKA .
Positive Preemptive Analgesia Effectiveness of Pregabalin Combined with Celecoxib in Total Knee Arthroplasty: A Prospective Controlled Randomized Study.
Pain Res Manag . 2023 Jan 12:2023:7088004.160 patients with knee osteoarthritis, undergoing total knee arthroplasty were randomized to receive either pregabalin + celecoxib (n=40), celecoxib alone (n=40), pregabalin alone (n=40), or placebo (n=40). Outcomes of interest included pain at rest and with movement on a Visual Analog Scale (VAS), sufentanil cumulative dose, high-sensitivity C-reactive protein (hs-CRP), range of motion (ROM), and the incidence of postoperative complications. Pain, opioid use, hs-CRP levels, and ROM were assessed up to 48 hours with ROM being assessed at 72 hours as well. Overall, the use of pregabalin + celecoxib for managing postoperative pain, improving ROM, decreasing opioid use, and reducing the hs-CRP levels showed superiority over placebo and celecoxib or pregabalin alone.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
